ArticleThe Journal of infectious diseases2018

Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.

Elfriede Agyemang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.